Sulindac Tablet
Product Images NDC 72789-373

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 72789-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789373 Label (72789373)

72789373 Label (72789373)
This text provides information about a medication called Sulindac, which is available in tablet form. Each tablet contains 150 mg of Sulindac. The text advises to read the package insert for full prescribing information and store the medication at 20° to 25°C (68° - 77°F). It recommends dispensing the tablets in a tight, light-resistant container. The tablets are debossed with "MP112". The text also mentions that the medication should be kept out of the reach of children and provides the manufacturing information of Frontida BioPharm, Inc. in Philadelphia, PA. A medication guide is available online at the provided link. The text also includes instructions for pharmacists to dispense the medication with the medication guide to each patient. The medication is marketed and packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City. The text includes some additional numbers and codes related to the medication.*
FDA Label Image

Structure (Sulindac 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.